Snake venom phospholipase A2 inhibitors: Medicinal chemistry and therapeutic potential

Current Topics in Medicinal Chemistry

Volumn 7, Issue 8, 2007, Pages 743-756

  Marcussi, Silvana ^a   Sant'Ana, Carolina D ^a   Oliveira, Clayton Z ^a   Quintero Rueda, Aristides ^a,b   Menaldo, Danilo L ^a   Beleboni, Rene O ^c   Stabeli, Rodrigo G ^d   Giglio, José R ^a   Fontes, Marcos R M ^e   Soares, Andreimar M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro de Investigación de Productos Naturales y Biotecnología   (Panama)

^c UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

^d UNIVERSIDADE FEDERAL DE RONDÔNIA   (Brazil)

^e SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Natural and artificial inhibitors; Phospholipase A2 inhibitors; Phospholipases A2; Snake venoms

Indexed keywords

4 [4 [2 [2 [BIS(4 CHLOROPHENYL)METHOXY]ETHYLSULFONYL]ETHOXY]PHENYL] 1,1,1 TRIFLUORO 2 BUTANONE; 4 NEOLIDYLCATECHOL; AMINO ACID; BMS 229724; BROWNEA ROSADE MONTE EXTRACT; CLERODANE DERIVATIVE; EDUNOL; FUCOIDIN; HELICONIA CURTISPATHA EXTRACT; LEMON EXTRACT; MANDEVILLA ILLUSTRIS EXTRACT; MANDEVILLA VELUTINA EXTRACT; MANOALIDE; MELANIN; MIKANIA GLOMERATA EXTRACT; MONOALOGUE; MONOCLONAL ANTIBODY; NATURAL PRODUCT; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE INHIBITOR; PLANT EXTRACT; PLEOPELTIS PERCUSSA EXTRACT; POLYCLONAL ANTIBODY; PTEROCARPAN DERIVATIVE; RENEALMIA ALPINIA EXTRACT; ROSMARINIC ACID; SNAKE VENOM; TABEBUIA ROSEA EXTRACT; TRICHOMANES ELEGANS EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; WEDELOLACTONE;

ANTIINFLAMMATORY ACTIVITY; BARK; BIOTECHNOLOGICAL PRODUCTION; BROWNEA ROSADE MONTE; DENATURATION; DRUG ISOLATION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TARGETING; ENVENOMATION; ENZYME BINDING; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME STRUCTURE; FRUIT; HELICONIA CURTISPATHA; HUMAN; IMMUNOMODULATION; LEMON; MANDEVILLA ILLUSTRIS; MANDEVILLA VELUTINA; MEDICINAL PLANT; MIKANIA GLOMERATA; MOLECULAR MODEL; NONHUMAN; PATHOPHYSIOLOGY; PLANT LEAF; PLANT ROOT; PLANT STEM; PLEOPELTIS PERCUSSA; PROTEIN MODIFICATION; RENEALMIA ALPINIA; REVIEW; RHIZOME; SNAKEBITE; STRUCTURE ACTIVITY RELATION; TABEBUIA ROSEA; THEA SINENSIS; TRICHOMANES ELEGANS;

ANIMALS; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; PHOSPHOLIPASES A; SNAKE VENOMS;

EID: 34247556051     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802607780487614     Document Type: Review

References (157)

1. Chippaux J. P. Snake-bites: Appraisal of the global situation. Bull World Health Organ 1998, 76, 515-524.
2. Chippaux J. P. The development and use of immunotherapy in Africa. Toxicon 1998, 36, 1503-1506.
3. Vital Brazil, O. Peçonhas. In: Farmacodinâmica; Corbett, C. E. Ed.; Editora Guanabara-Koogan: Rio de Janeiro, Brazil, 1982.
4. Gutiérrez, J. M.; Romero, M.; Nunez, J.; Chaves, F.; Borkow, G.; Ovadia, M. Skeletal muscle necrosis and regeneration after injection of BaH1, a hemorrhagic metalloproteinase isolated from the venom of the snake Bothrops asper (Terciopelo). Exp. Mol. Pathol. 1995, 62, 28-41.
5. Rucavado, A.; Gutiérrez, J. M. Snake venom metalloproteinases: Their role in the pathogenesis of local tissue damage. Biochimie 2000, 82, 841-850.
6. 2 miotóxicas. Master Thesis 2003, USP, Ribeirão Preto, 1-100.
7. 2. Comp. Biochem. Physiol. 2000, 127, 21-30.
8. Borges, M. H.; Soares, A. M.; Rodrigues, V. M.; Oliveira, F.; Fransheschi, A. M.; Rucavado, A.; Giglio, J. R.; Homsi-Brandeburgo, M. I. Neutralization of proteases from Bothrops snake venoms by the aqueous extract from Casearia sylvestris (Flacourtiaceae). Toxicon 2001, 39, 1863-1869.
9. Stabeli, R.G.; Magalhaes, L. M.; Selistre-de-Araujo, H. S.; Oliveira, E. B. Antibodies to a fragment of the Bothrops moojeni I-amino acid oxidase cross-react with snake venom components unrelated to the parent protein. Toxicon 2005, 46, 308-317.
10. 2 homologue: An example of function versatility of snake venom proteins. Comp. Biochem. Physiol. 2006, 142, 371-381.
11. 2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/ heparan sulfate family. Biochem. Pharmacol. 1994, 47 1509-1518.
12. 2 homologue from Bothrops neuwiedi pauloensis venom. Arch. Biochem. Biophys. 2000, 378, 201-209.
13. 2 from Bothrops asper snake venom. Arch. Biochem. Biophys. 1998, 358, 343-350.
14. 2 inhibition by manoalide. A novel type of phospholipase inhibitor. J. Biol. Chem. 1985, 260, 7234-7240.
15. 2 by manoalide and manoalogue. Stoichiometry of incorporation. J. Biol. Chem. 1991, 266, 16512-16517.
16. Melo, P. A.; Nascimento, M. C,; Mors, W. B.; Suarez-Kurtz, G. Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipa prostrata extracts and constituents. Toxicon 1994 32, 595-603.
17. Batina, M. F. C.; Cintra, A. C. O.; Veronese, E. L. G.; Lavrador, M. A. E.; Giglio, J. R.; Pereira, P. S.; Dias, D. A.; França, S. C.; Sampaio, S. V. Inhibition of the lethal and myotoxic activities of Crotalus durissus terríficus venom by Tabernaemontana catharinensis: Identification of one of the active components. Planta Medica 2000, 66, 424-428.
18. Biondo, R.; Pereira, A. M. S.; Marcussi, S.; Pereira, P. S.; França, S. C.; Soares, A. M. Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract.Biochimie 2003, 85, 1017-1025.
19. Mishra, L. C.; Singh, B. B.; Dagenais, S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review. Altern. Med. Rev. 2000, 5, 334-346.
20. Deepa, M.; Gowda, T. V. Purification and characterization of a glicoprotein inhibitor of toxic phospholipase from Withania somnifera. Arch. Biochem. Biophys. 2002, 408, 42-50.
21. Neves-Ferreira, A. G.; Cardinale, N.; Rocha, S. L.; Perales, J.; Domont, G. B. Isolation and characterization of DM40 and DM43, two snake venom metalloproteinase inhibitors from Didelphis marsupials serum. Biochim. Biophys. Acta 2000, 1474, 309-320.
22. Trento, E. P.; Garcia, O. S.; Rucavado, A.; França, S. C.; Batalini, C.; Arantes, E. C.; Giglio, J. R.; Soares, A. M. Inhibitory properties of the anti-bothropic complex from Didelphis albiventris serum on toxic and pharmacological actions of metalloproteases and myotoxins from Bothrops asper venom. Biochem. Pharmacol. 2001, 62, 1521-1529.
23. 2 inhibitor from the blood plasma of Agkistrodon blomhoffii siniticus. J. Biochem. 1993, 113, 413-419.
24. 2 inhibitor from the plasma of the South American rattlesnake (Crotalus durissus terrificus). J. Biol. Chem. 1994, 269, 15646-15651.
25. Perales, J.; Villela, C. G.; Domont, G. B.; Choumet, V.; Saliou, B.; Moussatché, H.; Bon, C.; Faure, G. Molecular structure and mechanism of action of the crotoxin inhibitor from Crotalus durisssus terrificus serum. Eur. J. Biochem. 1995, 227, 19-26.
26. 2 inhibitors from the blood plasma of the sea krait, Laticauda semifasciata. J. Biochem. 1999, 125, 375-382.
27. 2 myotoxin inhibitor protein from Bothrops moojeni snake plasma. Biochem. Biophys. 2003, 302, 193-200.
28. Domont, G. B.; Perales, J.; Moussatche, H. Natural anti-snake venom proteins. Toxicon 1991, 29, 1183-1194.
29. Bjarnason, J. B.: Fox, J. W. Hemorrhagic metalloproteinases from snake venoms. Pharmacol. Ther. 1994, 62, 325-372.
30. Thwin, M. M.; Gopalakrishnakone, P. Snake envenomation and protective natural endogenous proteins: A mini review of the recent developments (1991-1997). Toxicon 1998, 36 471-1482.
31. Perez, J. C.; Sanchez, E. E. Natural protease inhibitors to hemorrhagins in snake venoms and their potential use in medicine. Toxicon 1999, 37, 703-728.
32. 2 and myotoxins members of the innate immune system. In: Perspectives in Molecular toxinology, Ménez, A. Ed. Wiley: Chichester pp. 435-456, 2002.
33. 2. Biochimie 2000, 82, 833-840.
34. 2 in the blood plasma of snakes. Toxicon 2002, 40 481-484.
35. 2 myotoxin inhibitor proteins from snakes mammals and plants. Toxicon 2003, 42, 963-977.
36. 2 in eicosanoid generation. Am. J. Respir. Crit. Care. Med. 2000, 161, 32-35.
37. 2 homologue from Bothrops moojeni (Caissaca) snake venom. Arch. Biochem. Biophys. 2000, 373, 7-15.
38. Gutiérrez, J. M. Understanding snake venoms: 50 years of research in Latin America. Rev. Biol. Trop. 2002, 50, 377-394
39. 2. Biochemistry 1993, 32, 6484-6492.
40. 2 myotoxins from Bothrops snake venoms. Toxicon 1995, 33, 1405-1424.
41. Ownby, C. L. Structure, function and biophysical aspects of the myotoxins from snake venoms. J. Toxicol.-Toxins Rev. 1998, 17, 213-238.
42. 2+ on the phospholipase A and the presynaptic neuromuscular blocking actions of beta-bungarotoxin, crotoxin and taipoxin. Arch. Pharmacol. 1977, 299, 155-161.
43. Bon, C.; Changeux, J. P.; Jeng, T. W.; Fraenkel-Conrat, H. Postsynaptic effects of crotoxin and of its isolated subunits. Eur J Biochem. 1979, 99, 471-481.
44. 2 from elapid snake venoms. Toxicol. Appl. Pharmacol. 1981, 59, 375-388.
45. 2, a new class of HIV inhibitors that block virus entry into host cells. J. Clin. Invest. 1999, 104, 611-618.
46. 2 blocks malaria parasite development in the mosquito midgut by inhibiting ookinete association with the midgut surface. J. Exp. Biol. 2001, 204, 4157-4167.
47. 2-dependent induction of cyclooxygenase-2 in macrophages. J. Biol. Chem. 1999, 274, 25967-25970.
48. 2. Trends. Pharmacol. Sci. 1999, 20 162-170.
49. 2 enzymes: Classification and characterization. Biochim. Biophys. Acta 2000, 1488, 1-19.
50. 2 proteins. Toxicon 1999, 37, 411-445.
51. Gutiérrez, J. M.; Ownby, C. L.; Odell, G. V. Isolation of a myotoxin from Bothrops asper venom: Partial characterization and action on skeletal muscle. Toxicon 1984, 22, 115-28.
52. Gutiérrez, J. M.; Chaves, F.; Gene, J. A.; Lomonte, B.; Camacho, Z.; Schosinsky, K. Myonecrosis induced in mice by a basic myotoxin isolated from the venom of the snake Bothrops nummifer (jumping viper) from Costa Rica. Toxicon 1989, 27, 735-745.
53. Duncan, C. J. Role of intracellular calcium promoting muscle damage: A strategy for controlling the dystrophic condition. Experientia 1978, 34, 1531-1535.
54. 2 complex. Toxicon 1984, 22, 85-98.
55. 2 a structural review. Toxicon 1996, 34, 827-841.
56. 2. J. Biochem. 2002 131, 285-292.
57. 2+-binding ligand. Eur. J. Biochem. 1981 113, 283-288.
58. 2 isozymes from Trimeresurus gramineus (green habu snake) venom. Toxicon 1993, 31, 957-967.
59. 2. Role of histidine and calcium ion in the catalytic mechanism. Biochemistry 1980, 19, 743-750.
60. Rodrigues, V. M.; Soares, A. M.; Mancin, A. C.; Fontes, M. R. M.; Homsi-Brandeburgo, M. I.; Giglio, J. R. Geographic variations in the composition of myotoxins from Bothrops neuwiedi snake venoms: biochemical characterization and biological activity. Comp. Biochem. Physiol. 1998, 121, 215-222.
61. 2 from Bothrops pirajai snake venom. Arch. Biochem. Biophys. 2001, 387, 188-196.
62. 2 from snake venoms: Effects on catalytic and pharmacological properties. Toxicon 2003, 42, 855-868.
63. Homsi-Brandeburgo, M. I.; Queiroz, L. S.; Santo-Neto, H.; Rodrigues-Simioni, L.; Giglio, J. R. Fractionation of Bothrops jararacussu snake venom: Partial chemical characterization and biological activity of bothropstoxin. Toxicon 1988, 26 615-627.
64. Soares, A. M.; Rodrigues, V. M.; Homsi-Brandeburgo, M. I.; Toyama, M. H.; Lombardi, F. R.; Arni, R. K.; Giglio, J. R. A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: Biochemical characterization, crystallization, myotoxic and edematogenic activity. Toxicon 1998, 36 503-514.
65. 2 homologues are reduced, but not abolished, by a pH-induced dissociation. Toxicon 2005, 46, 291-296.
66. 2 in Bothrops snake venom: Effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu. Biochimie 2000, 82, 755-763.
67. 2 isolate from Lachesis muta (bushmaster) snake venom. Thromb. Haemost. 1997, 78, 1372-1380.
68. 2 isolated from Lachesis muta (Bushmaster) snake venom. Toxicon 2000, 38, 961-972.
69. 2 isolated from Lachesis muta snake venom. Comparison with lysophosphatidyleholine. Int. J. Biochem. Cell. Biol. 2003 35, 1470-1478.
70. Ouyang, C.; Yeh, H. I.; Huang, T. F. A potent platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom. Toxicon 1983, 21, 797-804.
71. 2 platelet inhibitor. Toxicon 1994, 32, 915-925.
72. 2 from Bothrops lanceolatus (fer de lance) venom: molecular and enzymatic properties. Toxicon 1994, 32 1069-1081.
73. 2 from Bothrops neuwiedii venom. Arch Biochem Biophys. 1995, 318, 65-70.
74. 2 isoform isolated from Bothrops neuwiedii (Yarara chica) venom with novel kinetic and chromatographic properties. Toxicon 1997, 35, 1205-1215.
75. 2 from the venom of Trimeresurus jerdonii snake. Toxicon 2002, 40, 1313-1319.
76. 2 from Bothrops jararacussu snake venom. Biochem. Pharmacol. 2002, 64, 723-732.
77. 2 in the action of general anesthetics. Am. J. Physiol. 1996, 270, 636-644.
78. 2 basic and clinical aspects in inflammatory diseases. Uhl, W.; Nevalainen, T. J.; Buchler, M. W.; Eds. Karger Ed. pp. 214-224, 1997.
79. 2 basic and clinical aspects in inflammatory diseases. Uhl, W.; Nevalainen, T. J.; Buchler, M. W.; Eds. Karger Ed. pp. 17-22, 1997.
80. 2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region. Toxicon 2005 45, 807-815.
81. Mors, W. B.; Nascimento, M. C.; Pereira, B. M. R.; Pereira, N. A. Plant natural products active against snake bite: The molecular approach. Phytochemistry 2000, 55, 627-642.
82. 2 in Bothrops moojeni venom: A promising approach to an enhanced antivenom production. Int. J. Biochem. Cell. Biol. 2004, 36, 258-270.
83. Soares, A. M.; Marcussi, S.; Lourenço, M. V.; Januário, A. H.; Sampaio, S. V.; Giglio, J. R.; Lomonte, B.; Pereira, P. S. Medicinal plants with inhibitory properties against snake venoms. Curr. Med. Chem. 2005, 12, 2625-2641.
84. Soares, A. M.; Januário, A. H.; Lourenço, M. V.; Pereira, A. M. S.; Pereira, P. S. Neutralizing effects of Brazilian plants against snake venoms. Drugs Future 2004, 29, 1105-1117.
85. 2 inhibitors from marine organisms. J. Nat. Prod. 1992, 55, 1701-1717.
86. Middleton, E. J. Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol. 1998, 439, 175-182.
87. 2 myotoxins. Toxicon 1999, 37, 199-215.
88. 50 (i.m.) and of the neutralization of the lethal effects of Crotalus durissus terrificus venom by the plant Peschiera fuchsiaefolia (Apocynaceae). J. Venom. Animals Toxins 1997, 3, 23-31.
89. Mors, W. B.; Nascimento, M. C.; Parente, J. P.; Da Silva, M. H.; Melo, P. A.; Suarez-Kurtz, G. Neutralization of lethal and myotoxic activities of South American rattlesnake venom by extracts and constituents of the plant Eclipta prostata (Asteraceae). Toxicon 1989, 27, 1003-1009.
90. Pithayanukul, P.; Laovachirasuwan, S.; Bavovada, R.; Pakmanee, N.; Suttisri, R. Anti-venom potential of butanolic extract of Eclipta prostata against Malayan pit viper venom. J. Ethnopharmacol. 2003, 90, 347-352.
91. Januário, A. H.; Santos, S. L.; Marcussi, S.; Mazzi, M. V.; Pietro, R. C. L.; Sato, D. N.; Sampaio, S. V.; França, S. C.; Soares, A. M. Neo-clerodane diterpenoid, a new metalloprotease snake venom inhibitor from Baccharis trimera (Asteraceae): Anti-proteolytic and anti-hemorrhagic properties. Chem.-Biol. Interactions 2004 150, 243-251.
92. Mors, W. B. Plants active against snake bite. Econ. Med. Plant Res. 1991, 5, 352-382.
93. Martz, W. Plant with a reputation against snakebite. Toxicon 1992, 30, 1131-1142.
94. Otero, R.; Núnez, V.; Jiménez, S. L.; Fonnegra, R.; Osorio, R. G.; Garcia, M. E.; Diaz, A. Snakebites and ethnobotany in the nortwest region of Colombia. Part II: Neutralization of lethal and enzymatic effects of Bothrops atrox venom. J. Ethnopharmacol. 2000, 71, 505-511.
95. 2 and phospholipase C. Eur. J. Pharmacol. 1993, 243, 213-219.
96. Biondo, R.; Soares, A. M.; Bertoni, B. W.; França, S. C.; Pereira, A. M. Direct organogenesis of Mandevilla illustris (Vell Woodson and effects of its aqueous extract on the enzymatic and toxic activities of Crotalus durissus terrificus snake venom. Plant Cell Rep. 2004, 22, 549-552.
97. Castro, O.; Gutiérrez., J. M.; Barrios, M.; Castro, I.; Romero, M.; Umana, E. Neutralization of the hemorrhagic effect induced by Bothrops asper (Serpentes: Viperidae) venom with tropical plant extracts. Rev. Biol. Trop. 1999, 47, 605-616.
98. 2 and antivenin activity of melanin extracted from Thea sinensis Linn. Lif Sci. 2004, 74, 2037-2047.
99. da Silva, A. J.; Coelho, A. L.; Simas, A. B.; Moraes, R. A.; Pinheiro, D. A.; Fernandes, F. F.; Arruda, E. Z.; Costa, P. R.; Melo, P. A. Synthesis and pharmacological evaluation of prenylated and benzylated pterocarpans against snake venom. Bioorg. Med. Chem. Lett. 2004, 14, 431-435.
100. Almeida, L.; Cintra, A. C.; Veronese, E. L.; Nomizo, A.; Franco, J. J.; Arantes, E. C.; Giglio, J. R.; Sampaio, S. V. Anticrotalic and antitumoral activities of gel filtration fractions of aqueous extract from Tabernaemontana chatarinensis (Apocynaceae). Comp. Biochem. Physiol. 2004, 137, 19-27.
101. Maiorano, V. A.; Marcussi, S.; Daher, M. A.; Oliveira, C. Z.; Couto, L. B.; Gomes, O. A.; França, S. C.; Soares, A. M.; Pereira, P. S. Antiophidian properties of the aqueous extract of Mikania glomerata. J. Ethnopharmacol. 2005, 102, 364-370.
102. Izidoro, L. F. M.; Rodrigues, V. M.; Rodrigues, R. S.; Ferro, E. V.; Hamaguchi, A.; Giglio, J. R.; Homsi-Brandeburgo, M. I. Neutralization of some hematological and hemostatic alterations induced by neuwiedase, a metalloproteinase isolated from Bothrops neuwiedi pauloensis snake venom, by the aqueous extract from Casearia mariquitensis (Flacourtiaceae), Biochimie 2003, 85, 669-675.
103. Alam, M. I.; Gomes, A.; Auddy, B. Viper venom neutralization by Indian medicinal plant (Hemidesmus indicus and Pluchea indica) root extracts. Phytother. Res. 1996, 10, 58-61.
104. Batina, M. F. C.; Giglio, J. R.; Sampaio, S. V. Methodological care in the evaluation of the LD50 and of the neutralization of the lethal effect of Crotalus durissus terrificus venom by the plant Peschiera fuchsiaefolia (Apocynaceae). J. Venom. Animal Toxins 1997, 3, 23-31.
105. Mahanta, M.; Mukherjee, A. K. Neutralization of lethality, myotoxicity and toxic enzimes of Naja kaouthia venom by Mimosa pudica root extracts. J. Ethnopharmacol. 2001, 75, 55-60
106. Alam, M. I.; Gomes, A. Snake venom neutralization by Indian medicinal plants (Vitex negudo and Emblica officinalis) root extracts. J. Ethnopharmacol. 2003, 86, 75-80.
107. Asuzu, I. U.; Harvey, A. L. The antisnake venom activities of Parkia biglobosa (Mimosaceae) stem bark extract. Toxicon 2003, 42, 763-768.
108. Castro, E. M.; Pinto, J. E. B.; Alvarenga, A. A.; Júnior Lima, E. C.; Bertolucci, S. K. V.; Filho, J. L. S.; Vieira, C. V. Crescimento e anatomia foliar de plantas jovens de Mikania glomerata Sprengel (guaco) submetidas a diferentes fotoperíodos. Ciência e Agrotecnologia 2003, 27, 1293-1300.
109. 2, myotoxic, hemorrhagic and lethal activities of crotalidae venoms. J. Ethnopharmacol. 2005, 98, 21-29.
110. Ferreira, L. A. F.; Henriques, O. B.; Andreoni, A. A. S.; Vital, G. R. F.; Campos, M. M. C.; Habermehl, G. G.; Moraes, V. L. G. Antivenom and biological effects of ar-turmerone isolated from Curcuma longa (Zingiberiaceae). Toxicon 1992, 30, 1211-1218.
111. Alam, M. I.; Gomes, A.; Auddy, B. Isolation, purafication and partial characterization of viper venom inhibiting factor from the root extract of the Indian medicinal plant sarsaparilla (Hemidesmus indicus R. Br.). Toxicon 1994, 32, 1551-1557.
112. 2 inhibitor from Cordia verbenacea (Boraginaceae): Antiserum action potentiation and molecular interaction. Toxicon 2005, 46, 318-327.
113. da Silva, J. o.; Coppede, J. S.; Fernandes, V. C.; Sant'ana, C. D.; Ticli, F. K.; Mazzi, M. V.; Giglio, J. R.; Pereira, P. S.; Soares, A. M.; Sampaio, S. V. Antihemorrhagic, antinucleolytic and other antiophidian properties of the aqueous extract from Pentaclethra macroloba. J. Ethnopharmacol. 2005, 100, 145-152.
114. Oliveira, C. Z.; Maiorano, V. A.; Marcussi, S.; Sant'ana, C. D.; Januário, A. H.; Lourenço, M. V.; Sampaio, S. V.; França, S. C.; Pereira, P. S.; Soares, A. M. Anticoagulant and antifibrinogenolytic properties of the aqueous extract from Bauhinia forficata against snake venoms. J. Ethnopharmacol. 2005, 98, 213-216
115. 2. Biochem. Pharmacol. 2003, 66, 1993-2000.
116. 2 from Bothrops snake venoms: Isolation of 4-nerolidylcatechol as active principle. Phytochemistry 2005, 66, 1017-1025.
117. 2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure. Biochemistry 2002, 41, 10914-10919.
118. 2 inhibition and modification by manoalogue. Am. Chem. Soc. 1988, 110, 5172-5177.
119. 2 by synthetic peptides derived from the primary sequence. J. Biol. Chem. 1996, 271, 23992-23998.
120. 2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. J. Pharmacol. Exp. Ther. 2001, 298, 376-385.
121. 2 from Bothrops asper snake venom: Pharmacological mediation and molecular determinants. Toxicon 2003, 41, 667-678.
122. 2 inhibitors. Bioorg. Med. Chem. Lett. 2004, 14, 3679-3681.
123. 2 from Crotalus durissus cascavella venom. Toxicon 2005, 46, 604-611.
124. Magro, A. J.; Takeda, A. A. S.; Soares, A. M.; Fontes, M. R. M. Structure of BthA-I complexed with p-bromophenacyl bromide: Possible correlations with lack of pharmacological activity. Acta. Crystallogr. 2005, 61D, 1670-1677.
125. 2-dependent effects of the venom from the New Guinean small-eyed snake Micropechis ikaheka. Muscle Nerve. 2005, 32, 81-87.
126. 2 and hyaluronidase enzymes. Bioorg. Med. Chem. Lett. 2005, 15, 4100-4104.
127. 2 from the venom of Vipera ammodytes meridionalis complexed to a synthetic inhibitor. Biochim. Biophys. Acta 2003, 1650, 1-3.
128. Omori-Satoh, T.; Sadahiro, S.; Ohsaka, A.; Murata, R. Purification and characterization of an antihemorrhagic factor in the serum of Trimeresurus flavoviridis, a crotalid. Biochim. Biophys. Acta 1972, 285, 414-426.
129. Ovadia, M.; Kochva, E. Neutralization of Viperidae and Elapidae snake venoms by sera of different animals. Toxicon 1977, 15 541-547.
130. Borkow, G.; Gutierrez, J. M.; Ovadia, M. Isolation, characterization and mode of neutralization of a potent antihemorrhagic factor from the serum of the snake Bothrops asper. Biochim. Biophys. Acta 1995, 1245, 232-238.
131. 2 myotoxins from the plasma of the snake of Bothrops asper. Biochem. J. 1997, 326, 853-859.
132. 2 from Bothrops venoms by the heteromeric protein complex of Didelphys albiventris opossum serum. Biochem. Mol. Biol. Int. 1997, 43, 1091-1099.
133. Rocha, S. L. G.; Lomonte, B.; Neves-Ferreira, A. G. C.; Domont, G. B.; Gutiérrez, J. M.; Perales, J. Functional analysis of DM64 an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum. Eur. J. Biochem. 2002, 269, 6052-6062.
134. Murari, S. K.; Frey, F. J.; Frey, B. M.; Gowda, T. V.; Vishwanath, B. S. Use of Pavo cristatus feather extract for the better management of snake-bites: Neutralization of inflammatory reactions. J. Ethnopharmacol. 2005, 99, 229-237.
135. 2 from Indian cobra (Naja Naja) venom. Biochimie 2004, 86, 203-210.
136. 2 inhibitors isolated from Bothrops jararacussu snake plasma. In preparation 2006.
137. 2 inhibitor from Lachesis muta muta (the bushmaster snake). Toxicon 2003, 41, 909-917
138. 2 isozymes in the snake's venom. Eur. J. Biochem. 1997, 249, 838-845.
139. 2 inhibitor from the blood plasma of Trimeresurus flavoviridis. Sequence homologies with pulmonary surfactant apoprotein and animal lectins. J. Biol. Chem. 1991, 266, 1001-1007.
140. 2 inhibitors from plasma of venomous snakes. Biochem. Mol. Biol. Int. 1997, 41, 529-537.
141. 2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffii siniticus. J. Biochem. 1997, 325, 527-531.
142. 2 binding and anti-inflammatory activity. Eur. J. Biochem. 2002, 269, 719-727.
143. 2 inhibitor from the blood plasma of Trimeresurus flavoviridis. J. Biochem. 1989, 106, 966-971.
144. Taylor, M. E.; Conary, J. T.; Lennartz, M. R.; Stahl, P. D.; Drickamer, K. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J. Biol. Chem. 1990, 265, 12156-12162.
145. 2 enzymes. Biochim. Biophys. Acta 2001, 1533, 29-37.
146. 2 inhibitor with leucine-rich repeats from the blood plasma of Agkistrodon blomhoffii siniticus: Sequence homologies with human leucine-rich α2-glycoprotein. J. Biol. Chem. 1998, 273, 19469-19475.
147. 2 inhibitor from the plasma of Thailand cobra having structural similar to urokinase-type plasminogen activator receptor and LY-6 related proteins. Biochem. Biophys. Res. Commun. 1994, 204, 1212-1218.
148. Fortes-Dias, C. L.; Fonseca, B. C.; Kochva, E.; Diniz, C. R. Purification and properties of an antivenom factor from the plasma of the South American rattlesnake (Crotalus durissus terrificus). Toxicon 1991, 29, 997-1008.
149. 2 inhibitor from the serum of the non-venomous snake Elaphe quadrivirgata. J. Biochem. 1999, 341, 165-171.
150. Santos, R. M. M.; Oliveira, L. C.; Estevão-Costa, M. I.; Lima, M.E.; Santoro, M. M.; Dias, C. L. Inhibition of crotoxin binding to synaptosomes by a receptor-like protein from Crotalus durissus terrificus (the South American rattlesnake). Biochim. Biophys. Acta 2005, 1717, 27-33.
151. 2 inhibitor in a nonvenomous snake Elaphe quadrivirgata. Arch. Biochem. Biophys. 2002, 408, 124-130.
152. 2 inhibitor from the blood plasma of Thailand cobra, Naja naja kaothia. Biochem. Biophys. Res. Commun. 1994, 200, 784-788.
153. 2 myotoxins from its own venom: Isolation molecular cloning, and biological properties. Biochem. J. 2000, 346, 631-639.
154. 2 inhibition and venom neutralizing potential. Biochem. 2000, 39, 9604-9611.
155. 2 inhibitors from Notechis ater serum. J. Biol. Chem. 2000, 275, 983-991.
156. 2 inhibitors from Australian elapid sera. Biochem. J. 2000, 346, 139-146.
157. 2 inhibitor from the serum of the common tiger snake (Notechis scutatus). J. Mol. Biol. 2001, 312, 875-884.